Deltagen Secures $10M in Equity, $5M Bridge Loan, Appoints Interim CEO

genomeweb
360dx

Deltagen Secures $10M in Equity, $5M Bridge Loan, Appoints Interim CEO

Apr 04, 2003

NEW YORK, April 4 - Existing institutional investors of Deltagen have agreed to purchase $10 million of the company's preferred stock in a private placement, Deltagen said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

DNA Methylation Changes Uncovered in Undernourished Children
Acute Myeloid Leukemia Regulatory Networks Identified
Top Five Articles on GenomeWeb Last Week: FDA, Illumina, PacBio, and More
Oxford BioDynamics Forms Autism Biomarker Alliance
Alzheimer's, Cardiovascular Disease Risk Overlap Uncovered by GWAS
People in the News: Marc Stapley, Jim Mullen, Scott Nicholson, More

The Scan

Critics Say Open-Access Plan 'Goes Too Far'

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

Science and the Science Committee

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

And Gone

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

This Week in PLOS

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.

Main menu